Viemed Healthcare

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Viemed Healthcare (VMD) surpasses Q3 revenue expectations, eyes strong 2025

Viemed Healthcare (VMD) delivered strong Q3 results, setting revenue records and showcasing operational improvements.
The company's focus on patient outcomes, regulatory advocacy, and strategic investments positions it for future growth.
Challenges include maintaining operational excellence, managing expenses, and navigating potential therapy impacts.
Viemed's opportunities lie in continued growth, regulatory developments, and strategic expansion for a positive outlook.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

VieMed's clinically proven care model being deployed in Arizona to improve outcomes in patients with impaired respiratory function VieMed's clinically proven care model being deployed in Arizona to improve outcomes in patients with impaired respiratory function

Commonwealth Primary Care ACO and VieMed Healthcare announce an innovative chronic respiratory care and sleep management alliance

Respiratory disease management contributes to growing healthcare costs in developed societies with aging demographics. There is a pressing need for Governments to reduce such healthcare costs. With 44% CAGR in revenue growth since 2010, Viemed exhibited strong fundamentals in addressing this healthcare need.

Strong Execution By Insider-Owners Ensures Viemed's Growth

LAFAYETTE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has been invited to present at Stifel Virtual Healthcare Conference, being held on Wednesday, November 18, 2020.

Viemed Healthcare to Present at Stifel Virtual Healthcare Conference on November 18, 2020

Viemed Healthcare, Inc.'s (VMD) CEO Casey Hoyt on Q3 2020 Results - Earnings Call Transcript

LAFAYETTE, La., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three and nine months ended September 30, 2020.

Viemed Healthcare Announces Third Quarter 2020 Financial Results

LAFAYETTE, La., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced its support for the Centers for Medicare & Medicaid Services' (“CMS”) recent decision to remove oxygen and positive airway pressure (“PAP”) devices from the Competitive Bidding Program (“CBP”) beginning January 1, 2021. CMS intended for 16 product categories to be included in the Round 2021 CBP. However, as previously disclosed, non-invasive ventilators were removed from the 2021 CBP in April 2020. Now, CMS has dropped 13 of the 15 remaining product categories, including oxygen and PAP therapies. CMS is only awarding CBP contracts for the off-the-shelf (“OTS”) Back Braces and OTS Knee Braces product categories. CMS's stated its reason for not awarding these 13 product categories was “because the payment amounts did not achieve expected savings.”

Viemed Healthcare Comments on Competitive Bidding Program

LAFAYETTE, La., Sept.  15, 2020  (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has been invited to present at Lake Street’s 4th Annual Best Ideas Growth (BIG4) Conference, being held on Thursday, September 17, 2020, on a virtual platform.

Viemed Healthcare to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference on September 17, 2020

Camping World Hlds

Forterra

MarineMax

Stride

Superior Uniform Group

Shutterstock

The mega-caps have had their day and now it’s time for small-cap stocks to take leadership positions on the market.
The post 7 ‘A-Rated’ Small-Cap Stocks That Could Bring Big Returns appeared first on InvestorPlace.

7 ‘A-Rated’ Small-Cap Stocks That Could Bring Big Returns

Abbott Labs

Teladoc

It's time for investors to adapt to a new normal.

4 Strategies for Investing During the Coronavirus Pandemic

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q2 2020 Results - Earnings Call Transcript

LAFAYETTE, La., Aug.  04, 2020  (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three and six months ended June 30, 2020.

Viemed Healthcare Announces Second Quarter 2020 Record Financial Results

Wayfair

Zoom Video

They've been outperforming the S&P 500 by wide margins this year.

3 Stocks to Buy and Hold During the Coronavirus Pandemic

LAFAYETTE, La., June  18, 2020  (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it expects to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, 2020 according to a preliminary list of additions posted June 5, 2020.

Viemed Healthcare to Join Russell 3000® Index

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q1 2020 Results - Earnings Call Transcript

LAFAYETTE, La., April  06, 2020  (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it is increasing its previously issued net revenue guidance for the first quarter of 2020.  In addition, the Company is providing an update on current operations and response to the growing number of COVID-19 cases around the country.

VIEMED HEALTHCARE RAISES FIRST QUARTER GUIDANCE AND PROVIDES UPDATE ON OPERATIONS AND RESPONSE TO COVID-19 VIRUS

LAFAYETTE, La., March  17, 2020  (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today its response to the growing number of COVID-19 cases around the country.

VIEMED HEALTHCARE ANNOUNCES RESPONSE TO COVID-19 VIRUS

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2019 Results - Earnings Call Transcript

News for Viemed Healthcare Stock (VMD)